CSIMarket
 
Nutra Pharma Corp  (NPHC)
Other Ticker:  
 
 

Nutra Pharma Growth Comparisons

Select each growth Category to receive further Information



NPHC Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 466.82 % -15.61 % 8.98 % 5.64 %
Q / Q Revenue Growth (Q3 MRQ) 20.83 % -16.43 % -5.09 % 0.25 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 189.87 % -13.32 % 11.26 % %
Seq. Revenue Growth (for 12 months ending Q3 TTM) 77.16 % -5.68 % 1.99 % 1.48 %
Revenue 5 Year Average Growth -19.63 % -17.19 % 8.97 % 11.56 %


NPHC's Growth Comparisons in III. Quarter 2022




Nutra Pharma reported top-line of $ 0 millions in the third quarter 2022, compare to $ 0 millions in the same quarter a year ago. Revenues in the Legal Cannabis industry fell by -15.61%, while the top-line in the Consumer Non Cyclical sector increased by 8.98%, and overall market improved by 5.64% from the third quarter 2021.

Company's sequential top-line increase was 20.83% from the second quarter. Average annual sales rise for Nutra Pharma is -19.63%, while S & P 500's average yearly sales growth is 11.56% over the five years, including only Businesses with the third quarter 2022 Results.


Growth Rates of NPHC's Income in the third quarter 2022


NPHC Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) - - 3.02 % -20.05 %
Seq. Operating Income Change (Q3 MRQ) - - 6.93 % -6.77 %
Y / Y Operating Income Growth (Q3 TTM) - - 4.15 % 3.5 %
Seq. Operating Income Growth (Q3 TTM) - - -0.4 % -5.38 %
Operating Income 5 Year Avg. Change - - 11.26 % 16.38 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -96.26 % - 4 % -21.2 %
Seq. Income from Cont. Ops. Change (Q3 MRQ) - - 8.34 % -17.26 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) - - 6.03 % -3.14 %
Seq. Income from Cont. Ops. Change (Q3 TTM) -67.76 % - -0.61 % -5.49 %
Income from Cont. Ops. 5 Year Avg. Change - - 9.26 % 19.91 %

NPHC Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -96.26 % - 3.5 % -19.35 %
Q / Q Net Income Growth (Q3 MRQ) - - 8.15 % -15.62 %
Y / Y Net Income Change (Q3 TTM) - - 6.14 % -4.05 %
Seq. Net Income Change (Q3 TTM) -67.76 % - -0.65 % -5.07 %
Net Income 5 Year Avg. Growth - - 9.66 % 20.18 %

NPHC's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) - - 4 % -21.2 %
Seq. EPS from Cont. Ops. Change (Q3 MRQ) - - 8.34 % -17.26 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) - -89.31 % - -
Seq. EPS from Cont. Ops. Change (Q3 TTM) 0 % -68.42 % - -36.1 %
EPS from Cont. Ops. 5 Year Avg. Growth - - 9.26 % 19.91 %



NPHC EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) - - 3.5 % -19.35 %
Q / Q EPS Net Growth (Q3 MRQ) - - 8.15 % -15.62 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - -89.84 % - -99.83 %
Seq. EPS Net Change (for 12 months ending Q3 TTM) 0 % -70.54 % - -99.83 %
EPS Net 5 Year Avg. Change - - 9.66 % 20.18 %



Nutra Pharma reported bottom-line of $ 0.00 in the third quarter, compare to $ 0.00 in the same quarter a year ago. Legal Cannabis industry fell by -15.61%, while Consumer Non Cyclical sector increased by 3.5%, and overall market declined by -19.35%.

The company's sequential bottom-line increase was 20.83% from the second quarter. Average annual income per share rise for Nutra Pharma is -19.63%, while S & P 500's average yearly income per share growth is 20.18% over the five years, including only Businesses with the third quarter 2022 earnings results.

NPHC Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - - 3.12 % -3.6 %
Seq. Free Cash Flow Change (Q3 MRQ) - - 96.91 % 25.82 %
Y / Y Free Cash Flow Change (Q3 TTM) - - -8.23 % 0.2 %
Seq. Free Cash Flow Change (Q3 TTM) - - -0.92 % -2.58 %
Free Cash Flow 5 Year Avg. Change - - 23.59 % 25.45 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - 68.81 % -
Seq. Net Cash Flow Change (Q3 MRQ) - - - -
Y / Y Net Cash Flow Change (Q3 TTM) - - - -
Seq. Net Cash Flow Change (Q3 TTM) - - - -
Net Cash Flow 5 Year Avg. Change 30.14 % - 21.08 % 125.83 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) - -66.75 % 0.86 % 0.33 %
Seq. Capital Expenditures Change (Q3 MRQ) - -49.88 % 1.86 % 90.04 %
Y / Y Capital Expenditures Change (Q3 TTM) 53.09 % 48.81 % 3.44 % -0.33 %
Seq. Capital Expenditures Change (Q3 TTM) -6.88 % -12.95 % -1.52 % -1.69 %
Capital Expenditures 5 Year Avg. Change - - 163.88 % 81.02 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com